Blood‐derived gene‐expression profiling in unravelling susceptibility to recessive disease

AUTOR(ES)

Vahteristo, P

FONTE

BMJ Group

RESUMO

Identification of new disease predisposition genes with chip‐based technologies typically requires extensive financial and sample resources. We have recently shown that combining peripheral blood genome and transcriptome (BGT) information in highly selected materials can be a successful low‐cost approach to unravelling dominant tumour susceptibility. In this study, we extended our investigations to recessively inherited tumour predisposition, and identified a homozygous germline mutation in the damage‐specific DNA binding protein 2 (DDB2) gene in a patient with several facial tumours, for which doctors had been unable to provide a diagnosis. Our results provide proof of principle that BGT is a powerful approach for both dominant and recessive genes. In addition to tumour susceptibility, the method may be useful in characterising genetic defects underlying other disease phenotypes.

Documentos Relacionados

• Combined histomorphometric and gene-expression profiling applied to toxicology
• Susceptibility of blood-derived monocytes and macrophages to caprine arthritis-encephalitis virus.
• Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice
• Orthologous gene-expression profiling in multi-species models: search for candidate genes
• Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration